Lupus anticoagulants and anti-phospholipid antibodies as risk factors for a first episode of ischemic stroke

Systemic lupus erythematosus in a multie

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients

✍ Jaime Calvo-Alén; Sergio M. A. Toloza; Mónica Fernández; Holly M. Bastian; Barri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a